2018 - Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials
Topics/Call fo Papers
Biomarkers, Clinical Trials, Life Sciences, Pharmaceutical
Other CFPs
- Digital Health: Optimizing Clinical Trials with Patient-Centric Technology
- Make Better Pharmaceutical Portfolio Decisions – Using Failure Rates to Understand Portfolio Risks and Improve R&D Productivity
- How to Effectively Communicate with FDA Regulators
- Strategic Implementation of a Rapid Molecular Blood Culture Panel for Gram-Negative Bacteremia
- RW- 535th International Conference on Science, Technology, Engineering and Management (ICSTEM)
Last modified: 2018-09-27 00:04:57